Last week we had the visit of our Dutch colleagues of ACTA and Ocello, partners in one of the Euopean projects that we are involved about Bone on a Chip. During two days we explained our developments of the last 6 months and discuss about possible improvements in the different areas involved in the design and validation of the new device.

BONAFIDE will develop, validate and deliver an in vitro human bone-on-chip platform that will simulate bone growth, resorption and remodeling for medium/ high throughput evaluation of drugs (e.g. anti-osteoporosis, nutrients, and biomaterials (e.g. bone cements). The BONAFIDE platform can be directly implemented in the preclinical workflow of companies and consists of a microfluidic chip containing a bone-mimetic matrix and standard operating procedures for human bone culture.

To build organs on a chip, it is neccesary to combine multiple types of cells from an organ on a microfluidic chip, while steadily supplying nutrients, removing waste, and applying mechanical forces the tissues would face in the body. In the future, the researchers could potentially grow human bones  in immune-deficient mice.

Organoids on chip

What is an organoid and why use it in research? There has been an increasing shift towards the development of 3D cell culture models in attempts to create an increased complexity that can be compared with the in vivo better than 2D models. From the different 3D...

BE-Transflow device as an epithelium-on-a-chip model for permeability studies

Researchers from the University of Zaragoza have employed the Be-Transflow device to develop a stratified epithelia-on-a-chip model, highlighting this device as a useful platform for permeability studies.     Replicating the permeability of a tissue barrier is pivotal...

BE-Gradient Barrier-Free applications: Hydrogel confinement and diffusion profile

Introduction Our new design BE-Gradient Barrier-Free is a device designed for 3D culture where a central chamber is linked with two fluidic lateral channels (Figure 1). The innovation we present is the absence of any physical barrier between the central chamber and...

BE-Doubleflow App. notes: Gut-on-chip 2

Introduction In our previous technical note “BE-Doubleflow App. notes: Gut-on-chip 1” we explored our device BE-Doubleflow for gut-on-a-chip (GOC) models in collaboration with AINIA. In that note we compared our device with an insert platform with GOC outperforming...

Project: MITI2

MITI2: Gut Microbiota-Induced Tregs for Inflammatory-Bowel-Disease (IBD) Immunotherapy Last 5th of July, we took part in the kick-off meeting in Nantes of a R&D project lead by INSERM in which Beonchip will be participating in the next 4 years.MITI2 focuses on the...